| |
EuroHIV-HepMtg2024: Efficacy of Dolutegravir (DTG) and Lamivudine (3TC) in Adults With HIV-1 and Isolated Reactive Hepatitis B Core Antibody (Anti-HBc): Results From the Phase 3 GEMINI-1/-2, TANGO, and SALSA Studies
|
| |
| |
European Meeting on HIV & Hepatitis; May 22-24, 2024; Barcelona, Spain
Dainielle Fox,1 Jihad Slim,2,3 Edgar T. Overton,1 Andrés Doblado-Maldonado,4 Peter Jeffery,5 Richard A. Grove,5 Chris M. Parry,6 Mark Underwood,1 Bryn Jones6
1ViiV Healthcare, Durham, NC, USA; 2New York Medical College, Valhalla, NY, USA; 3Saint Michael’s Medical Center, Newark, NJ, USA; 4ViiV Healthcare, Wavre, Belgium; 5GSK, Brentford, UK; 6ViiV Healthcare, Brentford, UK
presenting author: Dainielle Fox; dainielle.x.fox"at"viivhealthcare.com
|
|
| |
| |
|
|
|
